Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |